Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.

Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill University, Montreal, Canada.
The International Journal of Tuberculosis and Lung Disease (Impact Factor: 2.76). 02/2007; 11(1):16-26.
Source: PubMed

ABSTRACT Interferon-gamma release assays (IGRA) are now available alternatives to tuberculin skin testing (TST) for detection of latent tuberculosis infection (LTBI). We compared the cost-effectiveness of TST and IGRA in different populations and clinical situations, and with variation of a number of parameters.
Markov modelling was used to compare expected TB cases and costs over 20 years following screening for TB with different strategies among hypothetical cohorts of foreign-born entrants to Canada, or contacts of TB cases. The less expensive commercial IGRA, Quanti-FERON-TB Gold (QFT), was examined. Model inputs were derived from published literature.
For entering immigrants, screening with chest radiograph (CXR) would be the most and QFT the least cost-effective. Sequential screening with TST then QFT was more cost-effective than QFT alone in all scenarios, and more cost-effective than TST alone in selected subgroups. Among close and casual contacts, screening with TST or QFT would be cost saving; savings with TST would be greater than with QFT, except in contacts who were bacille Calmette-Guérin (BCG) vaccinated after infancy.
Screening for LTBI, with TST or QFT, is cost-effective only if the risk of disease is high. The most cost-effective use of QFT is to test TST-positive persons.

  • Canadian Medical Association Journal 07/2014; 186(16). DOI:10.1503/cmaj.131430 · 5.81 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: National policies regarding the BCG vaccine for tuberculosis vary greatly through-out the international community and several countries are currently considering discontinuing universal vaccination. Detractors of BCG point to its uncertain effectiveness and its interference with the detection and treatment of latent tuberculosis infection (LTBI). In order to quantify the trade-off between vaccination and treatment of LTBI, a mathematical model was designed and calibrated to data from Brazil, Ghana, Germany, India, Mexico, Ro-mania, the United Kingdom and the United States. Country-specific thresholds for when LTBI treatment outperforms mass vaccination were found and the consequences of policy changes were estimated. Our results suggest that vaccination outperforms LTBI treatment in all settings but with greatly reduced efficiency in low incidence countries. While national policy statements emphasize BCG's interference with LTBI detection, we find that reinfection should be more determinant of a country's proper policy choice.
    Mathematical Modelling of Natural Phenomena 01/2012; 7(3). DOI:10.1051/mmnp/20127307 · 0.73 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Exposure to premigratory traumatic events is common in refugees and non-refugee immigrants who have left their countries to escape socio-political turmoil. We conducted an evidence review to determine the burden of post traumatic stress disorder (PTSD) within immigrant and refugee populations, to evaluate the effectiveness of screening and treatment and to identify barriers for primary care. Methods: Using the GRADE approach, we systematically assessed evidence on PTSD screening and treatments and reviewed evidence for clinical considerations and implementation issues for newly arriving immigrants and refugees to Canada. Results: The prevalence of PTSD in refugees is approximately 9%, and, although comorbidity with depression is high, it generally has a favourable prognosis. Routine administration of brief screening tools for PTSD has yet to demonstrate clear benefits and could be harmful. The presence of unexplained somatic symptoms, sleep disorders, or of mental health disorders like depression or panic disorder however, should alert the practitioner to the possibility of PTSD. Culturally adapted psychological treatments appear promising for PTSD in refugees, but more research is needed. Pharmacotherapy is not recommended as a first line treatment although it may be helpful for severe sleep problems or co- morbid depression. In the case of asylum seekers a phased approach is recommended: interventions should focus on practical family and social supports, until safety has been objectively established. Subsequent treatment should address patient priorities including treatment of PTSD symptoms and support for social integration. Interpretation: Primary care practitioners need to be aware that exposure to traumatic events is likely in newly arrived immigrants and refugees. Empathy, reassurance and advocacy are key elements to establish an alliance and provide a sense of safety. Partnership with community organisations help to reduce isolation and support social integration. A system of clinical and institutional support for the practitioners is needed to prevent compassion fatigue.
    Canadian Medical Association journal 09/2011; · 5.81 Impact Factor


Available from